A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 92,160 shares of NVO stock, worth $9.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
92,160
Previous 86,678 6.32%
Holding current value
$9.7 Million
Previous $12.4 Million 11.31%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $652,741 - $797,192
5,482 Added 6.32%
92,160 $11 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $10.6 Million - $12.7 Million
86,678 New
86,678 $12.4 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.